Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
about
Is adiposopathy (sick fat) an endocrine disease?Heterogeneity of white adipose tissue: molecular basis and clinical implicationsFat in liver/muscle correlates more strongly with insulin sensitivity in rats than abdominal fat.Assessing Body Fat Changes during Moderate Weight Loss with Anthropometry and Bioelectrical Impedance.Inflammatory role of Toll-like receptors in human and murine adipose tissueAbdominal obesity: causal factor or simply a symptom of obesity-related health risk.Sex specific incidence rates of type 2 diabetes and its risk factors over 9 years of follow-up: Tehran Lipid and Glucose StudyAging, resistance training, and diabetes prevention.Relationship of adiposity and insulin resistance mediated by inflammation in a group of overweight and obese Chilean adolescents.Crosstalk between immune cells and adipocytes requires both paracrine factors and cell contact to modify cytokine secretion.Removal of intra-abdominal visceral adipose tissue improves glucose tolerance in rats: role of hepatic triglyceride storage.A systematic review of body fat distribution and mortality in older peopleRelationships of low serum vitamin D3 with anthropometry and markers of the metabolic syndrome and diabetes in overweight and obesity.Fat feeding potentiates the diabetogenic effect of dexamethasone in Wistar rats.Intra-abdominal adipose tissue is independently associated with sex-hormone binding globulin in premenopausal women.Waist circumference as measure of abdominal fat compartments.Using a novel coculture model to dissect the role of intramuscular lipid load on skeletal muscle insulin responsiveness under reduced estrogen conditions.Origins of metabolic complications in obesity: adipose tissue and free fatty acid trafficking.Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.Whole-body electromyostimulation as a means to impact muscle mass and abdominal body fat in lean, sedentary, older female adults: subanalysis of the TEST-III trial.Fenofibrate inhibits adipocyte hypertrophy and insulin resistance by activating adipose PPARalpha in high fat diet-induced obese miceIntermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular riskCentral sympathetic innervations to visceral and subcutaneous white adipose tissue.Insulin resistance, beta cell dysfunction and visceral adiposity as predictors of incident diabetes: the Insulin Resistance Atherosclerosis Study (IRAS) Family study.Phentermine, topiramate and their combination for the treatment of adiposopathy ('sick fat') and metabolic disease.Obesity, obstructive sleep apnoea and metabolic syndrome.Update on adipose tissue blood flow regulation.Visceral fat and metabolic inflammation: the portal theory revisited.Inflammation is associated with a decrease of lipogenic factors in omental fat in women.The herbal composition GGEx18 from Laminaria japonica, Rheum palmatum, and Ephedra sinica inhibits visceral obesity and insulin resistance by upregulating visceral adipose genes involved in fatty acid oxidation.Effects of weight loss on visceral and abdominal subcutaneous adipose tissue blood-flow and insulin-mediated glucose uptake in healthy obese subjects.Elevated adiponectin but varied response in circulating leptin levels to falciparum malaria in type 2 diabetics and non-diabetic controls.Behavior of insulin sensitivity and its relation to leptin and tumor necrosis factor-alpha in obese women undergoing liposuction: 6-month follow-up.Association between increased visceral fat area and alterations in plasma fatty acid profile in overweight subjects: a cross-sectional study.Substantial changes in epicardial fat thickness after weight loss in severely obese subjects.Abdominal fat deposits determined by magnetic resonance imaging in relation to leptin and vaspin levels as well as insulin resistance in the general adult population.Effect of weight loss on circulating fatty acid profiles in overweight subjects with high visceral fat area: a 12-week randomized controlled trial.Herbal Formula HT048 Attenuates Diet-Induced Obesity by Improving Hepatic Lipid Metabolism and Insulin Resistance in Obese Rats.Impaired insulin-mediated antilipolysis and lactate release in adipose tissue of upper-body obese women.Abdominal obesity and cardiometabolic risk in children and adolescents, are we aware of their relevance?
P2860
Q24655610-B15B5B4C-E0C9-4EB8-94A8-D0473EB94DDDQ26766498-C35A062E-FD10-429E-81CA-38180B3D8D80Q33379065-749E4D65-C617-49BF-B169-00E69922E661Q33637019-254D77A0-9A8B-40B0-B67D-0436E7EF0B39Q33746757-FDC82DA6-6989-4AFC-98FA-9A1CBFDBE986Q33874648-2C5F67E4-AA9E-47D3-9D16-72B1E9DED09AQ33910878-C6B7A084-9513-468D-B9F7-81A7CEF3EB3AQ34442619-6498A59F-A3E4-4B9B-8544-FAD17DBEA8E3Q34547038-6C476D96-340C-4DD8-9084-A224AC021C46Q35035166-37C85573-7AC2-44D7-B32C-7CC9A77C6140Q35243005-D3DC9BDF-5D98-4571-9C1F-A33F09DAF128Q36007757-94704521-47D8-4C69-A9B0-DADF8E12A0EBQ36492419-639D98E0-766D-4144-8D50-4CEC08E4D726Q36702009-1F1D874C-FCF0-4631-AB78-AE76FC04F2B0Q36765152-43675EE8-DC1C-4A87-94F4-F85147DF0306Q36879954-3C12FF67-E20F-469B-9E4C-E300DF9E9C84Q36923620-A74121F9-DE0D-411F-B4A0-7CC384B87D97Q37013861-CFBD53FC-F801-4CFA-9B58-E17A0F558184Q37117087-F6CD46F0-94CB-4D04-8D12-C7CB53BE06CCQ37226907-B1350021-3D28-4900-B4C1-E68EB1736EFFQ37250686-4FA615E6-5A5F-4856-8C44-0888E0CFB7E1Q37363649-8B217E68-8472-470F-AAE8-90FC175FB98DQ37629360-E923173D-953B-45F4-AC33-6FDBF9E0C9DEQ37712269-1F9B5BD4-FAED-40EF-AEA2-6A3143AE8970Q37779809-60E8C942-4916-4C47-8E53-779A6D28699CQ37944926-EB819110-827C-47A7-B6E8-B77623D5CB94Q37982682-A8813C4D-4586-48EC-B186-1438E11448B4Q38056228-F7DAA195-E1D2-46CA-A983-0DF0D225CB6BQ39986685-1ABDD9B9-AC83-47FA-8292-0DC2D7EDDA39Q42835215-11A239EA-F410-4D07-839C-096236C0CDFEQ46316659-31EBC454-5A0B-449A-8B78-2A93934C4F93Q46677141-31EA2E1B-A859-4744-9CCC-8484CC96F03DQ46854792-7BC4AF88-8024-461C-A38B-E906ED7188C2Q47142761-421E0EEC-0077-42F2-8461-DA3F82B9D79FQ47235442-685E6187-6F9A-40C9-93FC-2578EE9BDE09Q50026043-FA3082CD-9972-4879-84DD-FBDCFDBDC708Q51151761-48F4E378-FAE2-4B56-A05D-7AB628A5B74AQ53134487-770C0BA3-2F4B-45E0-90F1-5583DACBE182Q54106929-B3EC6693-38F7-4C93-991C-E8B4D9733A15Q57825533-B3CF1D16-BF7D-40C3-8078-536E60356771
P2860
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@ast
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@en
type
label
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@ast
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@en
prefLabel
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@ast
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@en
P2860
P356
P1433
P1476
Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model.
@en
P2093
Michael D Jensen
P2860
P304
P356
10.1038/OBY.2006.278
P478
14 Suppl 1
P577
2006-02-01T00:00:00Z